» Articles » PMID: 35806275

Oxidative Stress in Ageing and Chronic Degenerative Pathologies: Molecular Mechanisms Involved in Counteracting Oxidative Stress and Chronic Inflammation

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Jul 9
PMID 35806275
Authors
Affiliations
Soon will be listed here.
Abstract

Ageing and chronic degenerative pathologies demonstrate the shared characteristics of high bioavailability of reactive oxygen species (ROS) and oxidative stress, chronic/persistent inflammation, glycation, and mitochondrial abnormalities. Excessive ROS production results in nucleic acid and protein destruction, thereby altering the cellular structure and functional outcome. To stabilise increased ROS production and modulate oxidative stress, the human body produces antioxidants, "free radical scavengers", that inhibit or delay cell damage. Reinforcing the antioxidant defence system and/or counteracting the deleterious repercussions of immoderate reactive oxygen and nitrogen species (RONS) is critical and may curb the progression of ageing and chronic degenerative syndromes. Various therapeutic methods for ROS and oxidative stress reduction have been developed. However, scientific investigations are required to assess their efficacy. In this review, we summarise the interconnected mechanism of oxidative stress and chronic inflammation that contributes to ageing and chronic degenerative pathologies, including neurodegenerative diseases, such as Alzheimer's disease (AD) and Parkinson's disease (PD), cardiovascular diseases CVD, diabetes mellitus (DM), and chronic kidney disease (CKD). We also highlight potential counteractive measures to combat ageing and chronic degenerative diseases.

Citing Articles

Unveiling the geroprotective potential of Monarda didyma L.: insights from in vitro studies and a randomized clinical trial on slowing biological aging and improving quality of life.

Campisi M, Cannella L, Paccagnella O, Brazzale A, Agnolin A, Grothe T Geroscience. 2025; .

PMID: 40064804 DOI: 10.1007/s11357-025-01580-2.


Effects of Instant Pumpkin Soup on the Antioxidant Capacity and Oxidative Stress of the Elderly.

Irwan W, Setiawan B, Sulaeman A, Hardinsyah , Muhandri T Prev Nutr Food Sci. 2025; 30(1):21-27.

PMID: 40059914 PMC: 11884939. DOI: 10.3746/pnf.2025.30.1.21.


Investigation into recent advanced strategies of reactive oxygen species-mediated therapy based on Prussian blue: Conceptualization and prospect.

Kwon H, Jung Y, Jeon H, Han H Bioact Mater. 2025; 48:71-99.

PMID: 40034810 PMC: 11874232. DOI: 10.1016/j.bioactmat.2025.01.023.


Protective Effects of Oleanolic Acid on Human Keratinocytes: A Defense Against Exogenous Damage.

Vasarri M, Bergonzi M, Leri M, Castellacci R, Bucciantini M, De Marchi L Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40006051 PMC: 11859478. DOI: 10.3390/ph18020238.


Changes in the Expression Profile of Growth-Associated Protein 43 in Degenerative Lumbosacral Stenosis.

Sobanski D, Sobanska M, Staszkiewicz R, Strojny D, Grabarek B J Clin Med. 2025; 14(4).

PMID: 40004753 PMC: 11856692. DOI: 10.3390/jcm14041223.


References
1.
Remigante A, Spinelli S, Trichilo V, Loddo S, Sarikas A, Pusch M . d-Galactose induced early aging in human erythrocytes: Role of band 3 protein. J Cell Physiol. 2021; 237(2):1586-1596. PMC: 9299479. DOI: 10.1002/jcp.30632. View

2.
Amin A, Abd Elmageed Z, Nair D, Partyka M, Kadowitz P, Belmadani S . Modified multipotent stromal cells with epidermal growth factor restore vasculogenesis and blood flow in ischemic hind-limb of type II diabetic mice. Lab Invest. 2010; 90(7):985-96. PMC: 3154725. DOI: 10.1038/labinvest.2010.86. View

3.
WALKER E, Pacold M, Perisic O, Stephens L, Hawkins P, Wymann M . Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol Cell. 2000; 6(4):909-19. DOI: 10.1016/s1097-2765(05)00089-4. View

4.
Ilkun O, Boudina S . Cardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapies. Curr Pharm Des. 2013; 19(27):4806-17. PMC: 3856187. DOI: 10.2174/1381612811319270003. View

5.
Fayaz Ahmad S, Attia S, Bakheet S, Zoheir K, Ansari M, Korashy H . Naringin attenuates the development of carrageenan-induced acute lung inflammation through inhibition of NF-κb, STAT3 and pro-inflammatory mediators and enhancement of IκBα and anti-inflammatory cytokines. Inflammation. 2014; 38(2):846-57. DOI: 10.1007/s10753-014-9994-y. View